Ochre Bio: The RNA Therapy Aiming to End Reliance on Liver Transplants
Ochre Bio is an Oxford biotech developing RNA therapies for chronic liver disease, going from a Y Combinator seed round to a deal with Boehringer Ingelheim worth up to class="antialiased".3 billion.
Think & Rich